JONES EYECARE LTDActive

Company number SC756440Private limited companyIncorporated 2023

Key figures

£6,746-45.5%
Net assets 2025/26
+87.2%
Average annual growth 2023/24–2025/26
05 k10 k15 k2023/242024/252025/26

JONES EYECARE LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2023/242024/252025/26

Dividends

from the accounts
2025/26

Dividends paid in the financial year: £76,000 (108% of the profit for the year).

Filed accounts2023/24–2025/26
2023/242024/252025/26
Profit for the year——70,375
Cash at bank and in hand——3,609
Total assets162,525162,730156,687
Total liabilities157,403147,874146,116
Net assets / total equity1,92512,3716,746
Average number of employees202
Average pay (per year)——12,382
Dividends paid——76,000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: JONES EYECARE LTD

Company

JONES EYECARE LTD is a private limited company registered with Companies House under company number SC756440. It was incorporated on 24 Jan 2023. Its status is active. The registered office is in Aberdeen (AB25). Its nature of business (SIC 2007) is retail sale by opticians (47782).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files abridged accounts (unaudited). Profit for the year was £70,375. Net assets were £6,746, down 45.5% on the previous year. Cash at bank and in hand was £3,609. Total assets were £156,687 and total liabilities £146,116. The company had an average of 2 employees. Figures are available for 3 financial years (2023/24–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 6 Feb 2027.